Hosted on MSN22m
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause Nausea
The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While ...
Food27m
Is Ozempic’s impact on food and beverage sales exaggerated?
Consumers who take GLP-1 drugs might switch what they eat, but they largely spend the same amount of money on CPG food and ...
Hosted on MSN48m
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation
Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream. The ...